Clinical Plenary #2 | AASLD

Clinical Plenary #2

Nov 10 2025
Convention Center: Hall A (General Session), Concourse Level
8:30 AM - 9:30 AM
Live Streamed
Captured

World Class Speakers

Philip N Newsome, MD, PhD
Abstract Presenter

Philip N Newsome, MD, PhD

King's College London
Anna Lok, MD, FAASLD
Moderator

Anna Lok, MD, FAASLD

University of Michigan Medical Center
Michael R Lucey, MD, FRCPI, FAASLD
Moderator

Michael R Lucey, MD, FRCPI, FAASLD

University of Wisconsin School of Medicine and Public Health

Journey Maps

Presentations

8:30 AM - 8:45 AM
Oct 09 2026
Convention Center - Hall A (General Session), Concourse Level

Brelovitug (BJT-778) monotherapy achieved 100% virologic response in patients with chronic hepatitis D (CHD): On treatment Week 48 Phase 2 study results

Philip N Newsome, MD, PhD , Abstract Presenter
Hepatitis
MASLD
8:45 AM - 9:00 AM
Oct 09 2026
Convention Center - Hall A (General Session), Concourse Level

Weight-dependent and independent effects of semaglutide in participants with MASH: secondary analysis of the phase 3 ESSENCE trial

Philip N Newsome, MD, PhD , Abstract Presenter
Hepatitis
MASLD